Recent Finacing
Recent Raise
Clinical-stage biopharmaceutical in Watertown, MA that uses a synthetic-chemistry platform to discover and develop novel antibiotics, including IV and oral candidates targeting drug-resistant Gram-negative infections.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors